Keywords: AEterna Zentaris, Sanofi-Aventis, cetrorelix

AEterna Zentaris plunges as cetrorelix misses study endpoint

Article | 18 August 2009

Print This

AEterna Zentaris saw its share price plunge more than 62% to C$1.05 on August 17, after the Canadian company said that its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in